Evidence map›Paper›PMID 40375966›Full record

ArticleSAGE open medical case reports2025

Percutaneous stenting as treatment for chylothorax from superior vena cava syndrome: A case report.

Arta Kasaeian, Taylor Hoffman, Mohammad Ghasemi Rad, David Wynne, David Léon

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in SAGE open medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arta KasaeianDivision of Vascular and Interventional Radiology, Department of Radiology, Baylor College of Medicine, Houston, TX, USA.
Taylor HoffmanDivision of Vascular and Interventional Radiology, Department of Radiology, Baylor College of Medicine, Houston, TX, USA.
Mohammad Ghasemi RadDivision of Vascular and Interventional Radiology, Department of Radiology, Baylor College of Medicine, Houston, TX, USA.
David WynneDivision of Vascular and Interventional Radiology, Department of Radiology, Baylor College of Medicine, Houston, TX, USA.
David LéonDivision of Vascular and Interventional Radiology, Department of Radiology, Baylor College of Medicine, Houston, TX, USA.ORCID https://orcid.org/0000-0001-6560-0232

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superior vena cava syndrome is a condition that results from obstruction of the superior vena cava, the etiology of which can be benign or malignant. The impaired venous return can cause facial and upper extremity swelling, dyspnea, and neurologic symptoms. Chylothorax is a rare complication of superior vena cava syndrome. We report a case of a 69-year-old male with end-stage renal disease, who developed both a chylothorax and a contralateral simple pleural effusion secondary to superior vena cava syndrome. He was successfully treated with percutaneous endovascular stenting.

Indexed as

chylothoraxpercutaneous endovascular stentingsuperior vena cava syndrome (SVC)

Identifiers

PMID40375966
PMCPMC12078977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.